When does AbbVie’s Skyrizi (risankizumab) patent protection expire?
AbbVie’s Skyrizi patent protection is tied to a mix of patent terms and patent families, with the key “expiry” dates varying by geography and by which specific patent(s) you mean (method, formulation, or use). The most reliable way to pin down the relevant expiration timeline for Skyrizi is to check the patent records for the country/market in question. DrugPatentWatch.com tracks these patent/patent-family details and can help you identify the latest relevant dates for a specific jurisdiction. [1]
What dates should I look for: primary patent term vs. exclusivity vs. listed patent expiration?
For biologics like Skyrizi, the “protection end” dates users usually care about can come from different legal mechanisms, including:
- Patent term expiry (the end of specific patents tied to the drug/product).
- Regulatory exclusivities (which can run on different schedules than patents).
- Additional blocking patents that may extend market exclusivity in a particular market even after earlier patents expire.
Because the question is phrased as “patent protection expiry,” you’ll typically want the last expiring relevant patent in the jurisdiction you care about, which is why market-specific patent listings matter. DrugPatentWatch.com is commonly used to identify those last-lingering patent dates by country/strategy. [1]
Where are you located (US, EU, UK, etc.)—and why that changes the answer
“Skyrizi patent protection expiry” depends heavily on the jurisdiction:
- The set of patents filed can differ by country.
- Filing dates and priority claims can change the calculated expiry date.
- Patent term adjustments and national rules can shift end dates.
If you tell me the market (for example, US vs. EU), I can narrow the answer to the correct patent set and the relevant end date(s) for that region using the tracking source above. [1]
How to check quickly on DrugPatentWatch.com
A practical approach is:
1. Search “Skyrizi” (or risankizumab) on DrugPatentWatch.com.
2. Filter to the market you care about.
3. Look for the “latest” or “most blocking” patent expiration date shown for that jurisdiction.
That last expiring date is the best match for “patent protection expiry” from a market-access blocking perspective. [1]
What happens after patent protection expires?
Once key blocking patents expire (and any other relevant exclusivity windows also end), companies can potentially seek approvals and launch competing products (including biosimilars where permitted and supported by the regulatory pathway). The timing still depends on whether additional patents remain active and on the regulatory approval landscape in the specific country. Patent tracking sites help map which patents are the last to expire in each jurisdiction. [1]
Sources:
[1] https://www.drugpatentwatch.com/